Yakup Yürekli

Yakup Yürekli

Auto-generated profile, based on publicly available information

Yakup Yürekli

Adnan Menderes University Faculty of Medicine, Department of Nuclear Medicine, Aydın, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ACArzu Cengiz
Arzu Cengiz
ZKZehra Pınar Koç
Zehra Pınar Koç
PÖPınar Pelin Özcan
Pınar Pelin Özcan
YYYakup Yürekli
Yakup Yürekli
To investigate the role of 18F-FDG positron emission tomography/computed tomography (PET/CT) in detection of recurrence in ovarian cancer patients with increased CA-125 levels. Fifty-two patients (30-80 years old, mean: 58.5±10.6 years) who had been histopathologically diagnosed with ovarian cancer, underwent 18F-FDG PET/CT imaging for re-staging due to elevation of CA-125 levels were included in this retrospective study. 18F-FDG PET/CT findings were compared with histopathological, radiological and clinical follow-up results. CA-125 levels ranged between 35.2-2740 U/mL (N: 0-35 U/mL). Recurrent disease was detected in 45 of 52 patients on PET/CT imaging. There were three false negative and one false positive result. In addition to abdominal and pelvic lesions, 14 distant metastatic lesions (brain, lung, liver and bone metastasis) were identified correctly on PET/CT imaging. Sensitivity, specificity, positive and negative predictive value and accuracy of 18F-FDG PET/CT were calculated as 94%, 75%, 98%, 50% and 96%, respectively. 18F-FDG PET/CT is a useful imaging method that can be used in detection of ovarian cancer recurrence in patients with elevated CA-125 levels. Since this modality offers whole body imaging, distant metastases could be detected in addition to abdominal and pelvic lesions thus contributing to patient management.

1 October 2018 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ACArzu Cengiz
Arzu Cengiz
SGSibel Goksel
Sibel Goksel
YYYakup Yürekli
Yakup Yürekli
The aim of this study is to investigate the clinical role of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in patients with carcinoma of unknown primary (CUP). One hundred twenty one patients with a diagnosis of CUP who underwent whole body 18F-FDG PET/CT imaging were included in this retrospective study. The final diagnoses were confirmed either histopathologically or by clinical follow-up. The 18F-FDG-PET/CT successfully detected the primary tumor in 59 out of 121 (49%) patients. The most common primary tumor as detected by 18F-FDG PET/CT was lung cancer (n=31). In a patient, two primary tumors (colon and prostate) were detected on PET/CT imaging. Bone marrow biopsy revealed prostate cancer in this patient and the colon cancer was accepted as a synchronous second primary tumor. 18F-FDG PET/CT findings were false-positive in 11 patients. 18F-FDG PET/CT could not detect any primary lesion in 51 patients, whose conventional work-up detected a primary tumor in 11 and thus considered as false-negative. The sensitivity, specificity rate and accuracy of 18F-FDG PET/CT in detection of primary tumor were identified as 84%, 78% and 82%, respectively. Whole body 18F-FDG PET/CT is an effective method for detecting the primary tumor in patients with CUP. In addition to detecting the primary tumor, it can also help determine disease extent and contribute to patient management.

8 June 2018 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ACArzu Cengiz
Arzu Cengiz
SGSibel Goksel
Sibel Goksel
YBYeşim Başal
Yeşim Başal
ŞGŞule Taş Gülen
Şule Taş Gülen
FDFüruzan Kacar Döger
Füruzan Kacar Döger
YYYakup Yürekli
Yakup Yürekli
Laryngeal tuberculosis is a rare presentation of tuberculosis. It can mimic laryngeal carcinoma with its clinical and imaging findings. A 51-year old woman underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging for clinically suspected carcinoma of the larynx. PET/CT revealed lung lesions consistent with tuberculosis in additional to hypermetabolic focus on larynx. The patient was histopathologically diagnosed with lung and laryngeal tuberculosis.

28 May 2018 in Turkish Journal of Hematology
Verified
Journal Article
Open access
ACArzu Cengiz
Arzu Cengiz
HAHayri Üstün Arda
Hayri Üstün Arda
FDFüruzan Kacar Döger
Füruzan Kacar Döger
İYİrfan Yavaşoğlu
İrfan Yavaşoğlu
YYYakup Yürekli
Yakup Yürekli
ABAli Zahit Bolaman
Ali Zahit Bolaman
Objective: The aim of this study was to evaluate the relation between the rate of fluorine-18 (18F) fludeoxyglucose (FDG) uptake and CD38 and CD138 expression in myeloma cells in bone marrow and other clinical parameters in patients with multiple myeloma (MM). Materials and Methods: Patients with the diagnosis of MM who underwent 18F-FDG positron emission tomography/computed tomography (PET/CT) for initial staging were evaluated retrospectively. We analyzed a total of 42 patients (43-83 years old, mean: 64.4 +/- 9.9). Hematological and biochemical tests including hemoglobin, hematocrit, C-reactive protein, beta 2-microglobulin, creatinine, albumin, calcium, lactate dehydrogenase, and erythrocyte sedimentation rate were recorded. In bone marrow samples, plasma cell ratio and CD38 and CD138 immunohistochemical staining were evaluated. On PET/ CT images, mean standardized uptake values (SUVmean) of the right anterior and posterior iliac crest and right proximal femora were calculated. The correlations between the average SUVmean of bone marrow and CD38- and CD138-expressing myeloma cells and other parameters were analyzed by Spearman's correlation test. Values of p<0.05 were considered statistically significant. Results: Types of MM were IgG(K) (45%), IgG(L), (21%), IgA(K) (7%), IgA(L), (10%), and others (17%). Thirty-two (76%) patients were at stage III according to the Salmon-Durie staging system. There was a statistically significant positive correlation between bone marrow FDG uptake and percentage of plasma cells in bone marrow and CD38 and CD138 expression in plasma cells (r=0.403, r=0.339, and r=0.409) and beta 2-microglobulin and C-reactive protein levels (r=0.676, r=0.541). There was a negative correlation between bone marrow FDG uptake and hemoglobin and hematocrit values (r=-0.377 and r=-0.368). Other hematological parameters were not correlated with FDG uptake in bone marrow. Conclusion: Increased FDG uptake is correlated with the percentage of CD38 and CD138 expression in plasma cells in bone marrow. In addition to initial staging, 18F-FDG PET/CT is useful in treatment planning and prognostic evaluation in MM patients.

7 February 2025 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ATAhmet Tanyeri
Ahmet Tanyeri
RARıdvan Akbulut
Rıdvan Akbulut
ENEmir Hüseyin Nevai
Emir Hüseyin Nevai
YYYakup Yürekli
Yakup Yürekli
Correlation of 3T Diffusion-weighted MRI and 18F-FDG-PET/CT in Liver Metastases: SUV Versus ADC - Molecular Imaging and Radionuclide Therapy

1 January 2021 in Journal of Oncological Sciences
Verified
Journal Article
Open access
SGSibel Goksel
Sibel Goksel
ACArzu Cengi̇z
Arzu Cengi̇z
HÖHakan Öztürk
Hakan Öztürk
YYYakup Yürekli̇
Yakup Yürekli̇
For those who helped create the Genki Dama